National Health Investors (NHI) FY2019 results: revenue $318 million, up 8.0% on the year
National Health Investors Inc. (NHI) reported revenue of $318 million for fiscal 2019, the year ended 31 December 2019, up 8.0% on the year before. Net income was $160 million, up 4.0%, and diluted earnings per share $3.67. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2020.
Revenue
$318 million
+8.0% on the year
FY2012FY2019
Operating margin
50.7%
52.6% a year earlier
FY2012FY2019
Net income
$160 million
+4.0% on the year
FY2012FY2019
Diluted EPS
$3.67
0.0% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
318
295
279
+8.0%
Operating income
161
155
151
+4.0%
Operating margin
50.7%
52.6%
54.4%
Interest expense
56.3
49.1
46.3
+14.8%
Pre-tax income
161
155
151
+4.0%
Income tax
n/a
0.1
0.1
Effective tax rate
n/a
0.1%
0.1%
Net income
160
154
159
+4.0%
Net margin
50.4%
52.4%
57.2%
Diluted EPS
$3.67
$3.67
$3.87
0.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
241
208
198
+15.9%
Capital expenditure
237
148
176
+60.6%
Free cash flow
3.8
60.2
22.3
-93.7%
Free cash flow margin
1.2%
20.4%
8.0%
Cash from investing
-343
-250
-164
Cash from financing
107
44.3
-35.1
+142.5%
Share-based compensation
3.6
2.5
2.6
+46.4%
Dividends paid
180
165
153
+8.7%
Dividend per share
$4.20
$4.00
$3.80
+5.0%
Diluted shares, weighted
44m
42m
41m
+3.8%
Shares outstanding at period end
45m
43m
42m
+4.4%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
1,498
1,390
1,322
+7.8%
Non-controlling interest
0.6
0.0
n/a
Debt
1,440
1,282
1,145
+12.4%
Other liabilities
104
79.2
78.2
+30.7%
Total liabilities and equity
3,042
2,751
2,546
+10.6%
Fixed assets
2,560
2,367
2,286
+8.2%
Loans
340
246
141
+38.2%
Cash and equivalents
5.2
4.7
3.1
+11.9%
Receivables
3.2
6.4
2.4
-49.7%
Other assets
133
127
113
+5.3%
Total assets
3,042
2,751
2,546
+10.6%
10-K for the year ended 31 December 2019, filed 19 February 2020: the filing.